share_log

HC Wainwright & Co. Reiterates Neutral on CytomX Therapeuticsto Neutral

Benzinga ·  Jan 7 19:32

HC Wainwright & Co. analyst Mitchell Kapoor reiterates CytomX Therapeutics (NASDAQ:CTMX) from Neutral to Neutral.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment